Advertisement
<< Back To Article
FDA Approves First CRISPR Gene Therapy for Sickle Cell Disease
Clover lilac
The FDA’s approval of the first CRISPR gene therapy for sickle cell disease marks a groundbreaking moment in medical science. This innovative beverly hills psychiatrist approach offers hope for patients by targeting the genetic mutation at its root, potentially transforming treatment and providing a long-awaited cure for a debilitating condition.
February 17, 2025